Vertex Pharmaceuticals Incorporated
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2009 | $24.0M | $-161.9M | $-162.7M |
| Jun 2009 | $19.1M | $-157.2M | $-171.3M |
| Sep 2009 | $25.0M | $-148.2M | $-149.6M |
| Dec 2009 | $33.9M | $-146.7M | $-158.6M |
| Mar 2010 | $22.4M | $-160.3M | $-165.3M |
| Jun 2010 | $31.6M | $-169.6M | $-200.0M |
| Sep 2010 | $23.8M | $-199.6M | $-209.0M |
| Dec 2010 | $65.5M | $-166.6M | $-180.4M |
| Mar 2011 | $73.7M | $-159.9M | $-176.1M |
| Jun 2011 | $114.4M | $-165.9M | $-174.1M |
| Sep 2011 | $659.2M | $215.7M | $221.1M |
| Dec 2011 | $563.3M | $223.9M | $158.6M |
| Mar 2012 | $438.7M | $91.6M | $91.6M |
| Jun 2012 | $418.3M | $-10.8M | $-64.9M |
| Sep 2012 | $336.0M | $-1.1M | $-57.5M |
| Dec 2012 | $334.0M | $-77.5M | $-76.1M |
| Mar 2013 | $328.4M | $-429.1M | $-308.0M |
| Jun 2013 | $310.8M | $-47.0M | $-57.2M |
| Sep 2013 | $221.7M | $-123.6M | $-124.1M |
| Dec 2013 | $351.2M | $-10.3M | $44.3M |
| Mar 2014 | $118.5M | $-216.0M | $-232.5M |
| Jun 2014 | $138.4M | $-180.5M | $-159.4M |
| Sep 2014 | $179.0M | $-142.2M | $-170.1M |
| Dec 2014 | $144.6M | $-153.6M | $-176.7M |
| Mar 2015 | $138.5M | $-172.0M | $-198.6M |
| Jun 2015 | $166.1M | $-171.2M | $-188.8M |
| Sep 2015 | $309.8M | $-70.0M | $-95.1M |
| Dec 2015 | $417.9M | $-53.7M | $-73.7M |
| Mar 2016 | $398.1M | $-14.3M | $-41.6M |
| Jun 2016 | $431.6M | $3.4M | $-64.5M |
| Sep 2016 | $413.8M | $-18.7M | $-38.8M |
| Dec 2016 | $458.7M | $39.6M | $32.9M |
| Mar 2017 | $714.7M | $270.8M | $247.8M |
| Jun 2017 | $544.1M | $52.7M | $18.0M |
| Sep 2017 | $578.2M | $-326.0M | $-103.0M |
| Dec 2017 | $651.6M | $125.7M | $100.7M |
| Mar 2018 | $640.8M | $128.9M | $210.3M |
| Jun 2018 | $752.2M | $172.9M | $207.4M |
| Sep 2018 | $784.5M | $205.6M | $128.7M |
| Dec 2018 | $870.1M | $127.7M | $1.55B |
| Mar 2019 | $858.4M | $276.8M | $268.6M |
| Jun 2019 | $941.3M | $270.0M | $267.4M |
| Sep 2019 | $949.8M | $99.3M | $57.5M |
| Dec 2019 | $1.41B | $551.5M | $583.2M |
| Mar 2020 | $1.52B | $720.2M | $602.8M |
| Jun 2020 | $1.52B | $718.0M | $837.3M |
| Sep 2020 | $1.54B | $672.2M | $667.4M |
| Dec 2020 | $1.63B | $745.8M | $604.2M |
| Mar 2021 | $1.72B | $887.8M | $653.1M |
| Jun 2021 | $1.79B | $-37.9M | $67.0M |
| Sep 2021 | $1.98B | $1.05B | $851.9M |
| Dec 2021 | $2.07B | $877.7M | $770.1M |
| Mar 2022 | $2.10B | $1.04B | $762.1M |
| Jun 2022 | $2.20B | $1.11B | $810.5M |
| Sep 2022 | $2.33B | $1.13B | $930.5M |
| Dec 2022 | $2.30B | $1.03B | $818.9M |
| Mar 2023 | $2.37B | $779.0M | $699.8M |
| Jun 2023 | $2.49B | $1.03B | $915.7M |
| Sep 2023 | $2.48B | $1.04B | $1.04B |
| Dec 2023 | $2.52B | $988.5M | $968.8M |
| Mar 2024 | $2.69B | $1.14B | $1.10B |
| Jun 2024 | $2.65B | $-3.51B | $-3.59B |
| Sep 2024 | $2.77B | $1.12B | $1.05B |
| Dec 2024 | $2.91B | $1.03B | $913.0M |
| Mar 2025 | $2.77B | $630.1M | $646.3M |
| Jun 2025 | $2.96B | $1.15B | $1.03B |
| Sep 2025 | $3.08B | $1.19B | $1.08B |
| Dec 2025 | $3.19B | $1.21B | $1.19B |
| Mar 2026 | $2.99B | $1.14B | $1.03B |
| Jun 2026 | $3.33B | $1.25B | $1.10B |